PhoreMost, NeoPhore secure Innovate UK funding for small-molecule cancer immunotherapy program – Pharmaceutical Business Review
|
PhoreMost, NeoPhore secure Innovate UK funding for small-molecule cancer immunotherapy program
Pharmaceutical Business Review The companies are partners on a grant titled, "A novel small molecule approach to enhance cancer immunotherapy." Their research plan proposes to develop small-molecule drugs that will stimulate cancer immunity by leveraging well-validated genetic … |
